drugset / Trial / NCT01667666
Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
Phase 1
Terminated
13 enrolled
Denver Health and Hospital Authority
University of Colorado, Denver · collab
NaSingle-groupOpen-labelPrevention
Summary
This study evaluates the use of nebulized hypertonic saline (aerosolized salt water) as a preventive treatment for post-traumatic acute lung injury (ALI). Both animal and human research indicate that aerosolized salt water might help reduce harmful inflammation with minimal risks.
Timeline
- Start
- 2012-05
- Primary completion
- 2018-11-06
- Completion
- 2018-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 3 % | Inhaled |
| Subject | Hypertonic saline | Unknown | 4.5 % | Inhaled |
| Subject | Hypertonic saline | Unknown | 6 % | Inhaled |
| Subject | Hypertonic saline | Unknown | 7 % | Inhaled |